MB "Grožio injekcija" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| -766 |
| -766 |
| - |
| - |
| - |
| -1,952 |
| 1,952 |
| 0 |
| 0 |
| - |
| -1.00 |
| - |
| - |
| - |
| -766 |
| 2024 |
|---|
| 5,912 |
| - |
| 502 |
| 477 |
| - |
| 99.53 |
| 8.07 |
| -1,476 |
| 2,565 |
| 364 |
| 725 |
| -0.31 |
| -1.74 |
| - |
| - |
| 8.54 |
| 505 |
| 2025 |
|---|
| 9,966 |
| - |
| 1,064 |
| 1,000 |
| - |
| 97.47 |
| 10.03 |
| -475 |
| 2,999 |
| 267 |
| 2,257 |
| -0.07 |
| -6.31 |
| - |
| - |
| 10.68 |
| 1,064 |
| 2025 |
|---|
| 9,966 |
| - |
| 1,064 |
| 1,000 |
| - |
| 97.47 |
| 10.03 |
| -475 |
| 2,999 |
| 267 |
| 2,257 |
| -0.07 |
| -6.31 |
| - |
| - |
| 10.68 |
| 1,064 |
Turnover (€)
2025
Turnover (€)
9,966 €69 % *
Sales per employee (€)
-Profit before tax (€)
1,064 €112 % *
Net Profit (€)
1,000 €110 % *
Profit per employee (€)
-Total profitability (%)
97.47 %-2.07 % *
Net profitability (%)
10.03 %24.29 % *
Equity (€)
-475 €68 % *
Amounts Payable And Liabilities (€)
2,999 €17 % *
Non-current Assets (€)
267 €-27 % *
CurrentAssets (€)
2,257 €211 % *
Working capital requirement
-0.07 77.42 % *
Debt-to-equity ratio
-6.31 -262.64 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
10.68 %25.06 % *
EBIT (€)
1,064 €111 % *
